← All indications
Adrenocortical Hyperfunction
Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.
Subtype terms (2)
More specific conditions that are subtypes of Adrenocortical Hyperfunction in the MeSH hierarchy.
- Cushing Syndrome
35 drugs (24 approved, 11 experimental)
- Hyperaldosteronism
24 drugs (17 approved, 7 experimental)
Drugs by status
Approved for this indication (3)
Phase 2 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (12)
- Millendo Therapeutics, Inc.
- National Center for Research Resources (NCRR)
- Harvard University
- University of Michigan
- University of Bergen
- University of California, San Diego
- Feinstein Institute for Medical Research
- University of Minnesota
- Helse Bergen
- Spruce Biosciences
- Children's Hospital Los Angeles
- The University of Texas, Dallas
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (3)